Retraction: Microrna-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting sirtuin 1 (Oncology Reports (2015) 34 (399-406) DOI: 10.3892/or.2015.3986);MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1

Oncology Reports

Volumn 34, Issue 1, 2015, Pages 399-406

  Shi, Ying ^a   Huang, Jianjun ^b   Zhou, Jun ^a   Liu, Ying ^a   Fu, Xiaodan ^a   Li, Yimin ^a   Yin, Gang ^a   Wen, Jifang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b JISHOU UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Invasion; MicroRNA 204; Migration; Osteosarcoma; Proliferation; Sirtuin 1

Indexed keywords

MICRORNA; MICRORNA 204; NERVE CELL ADHESION MOLECULE; SIRTUIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; 3' UNTRANSLATED REGION; MIRN204 MICRORNA, HUMAN; SIRT1 PROTEIN, HUMAN;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MIGRATION INHIBITION; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIRT1 GENE; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; 3' UNTRANSLATED REGION; BONE TUMOR; CELL MOTION; CELL PROLIFERATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; SIRTUIN 1;

EID: 84930021925     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/OR.2021.8098     Document Type: Erratum

References (33)

1. Thompson LD: Osteosarcoma. Ear Nose Throat J 92: 288, 290, 2013.
2. Liang W, Gao B, Fu P, Xu S, Qian Y and Fu Q: The miRNAs in the pathgenesis of osteosarcoma. Front Biosci 18: 788-794, 2013.
3. Moss EG: MicroRNAs: Hidden in the genome. Curr Biol 12: R138-R140, 2002.
4. Choi E, Choi E and Hwang KC: MicroRNAs as novel regulators of stem cell fate. World J Stem Cells 5: 172-187, 2013.
5. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al: A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105: 13556-13561, 2008.
6. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
7. Li W, Jin X, Zhang Q, Zhang G, Deng X and Ma L: Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer. Int J Clin Exp Pathol 7: 3287-3292, 2014.
8. Xia Y, Zhu Y, Ma T, Pan C, Wang J, He Z, Li Z, Qi X and Chen Y: miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC. FEBS Lett 588: 3703-3712, 2014.
9. Zhang F, Huang W, Sheng M and Liu T: MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients. Tumour Biol: Nov 13, 2014 (Epub ahead of print).
10. Xu M, Jin H, Xu CX, Sun B, Mao Z, Bi WZ and Wang Y: miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma. Oncotarget 5: 9472-9483, 2014.
11. He Y, Meng C, Shao Z, Wang H and Yang S: MiR-23a functions as a tumor suppressor in osteosarcoma. Cell Physiol Biochem 34: 1485-1496, 2014.
12. Shen L, Wang P, Yang J and Li X: MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. PLoS One 9: e109138, 2014.
13. Wang Q, Cai J, Wang J, Xiong C and Zhao J: MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion. Tumour Biol 35: 12743-12748, 2014.
14. Jiang L, He A, Zhang Q and Tao C: miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9. Tumour Biol 35: 12645-12654, 2014.
15. Zhang K, Zhang Y, Ren K, Zhao G, Yan K and Ma B: MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression. Oncol Rep 32: 2143-2149, 2014.
16. Han K, Zhao T, Chen X, Bian N, Yang T, Ma Q, Cai C, Fan Q, Zhou Y and Ma B: microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R. Int J Oncol 45: 1437-1449, 2014.
17. Yang J and Zhang W: New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406, 2013.
18. Shi L, Zhang B, Sun X, Lu S, Liu Z, Liu Y, Li H, Wang L, Wang X and Zhao C: MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1. Br J Cancer 111: 2316-2327, 2014.
19. Zhou X, Li L, Su J and Zhang G: Decreased miR-204 in H. pyloriassociated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4. PLoS One 9: e101457, 2014.
20. Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H, Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res 73: 990-999, 2013.
21. Yoshitaka T, Kawai A, Miyaki S, Numoto K, Kikuta K, Ozaki T, Lotz M and Asahara H: Analysis of microRNAs expressions in chondrosarcoma. J Orthop Res 31: 1992-1998, 2013.
22. Zhang L, Wang X and Chen P: MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer 13: 290, 2013.
23. Li D, Bi FF, Chen NN, Cao JM, Sun WP, Zhou YM, Li CY and Yang Q: A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer. Sci Rep 4: 6666, 2014.
24. Lin L, Zheng X, Qiu C, Dongol S, Lv Q, Jiang J, Kong B and Wang C: SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis. Oncol Rep 32: 2831-2835, 2014.
25. Xu JQ, Liu P, Si MJ and Ding XY: MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1. Tumour Biol 34: 3871-3877, 2013.
26. Chu F, Chou PM, Zheng X, Mirkin BL and Rebbaa A: Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res 65: 10183-10187, 2005.
27. Li Y, Bäckesjö CM, Haldosén LA and Lindgren U: Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells. Eur J Pharmacol 609: 13-18, 2009.
28. Moustakas A and Heldin CH: Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520, 2007.
29. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006.
30. Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J, et al: VHL-regulated miR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 21: 532-546, 2012.
31. Sacconi A, Biagioni F, Canu V, Mori F, Di Benedetto A, Lorenzon L, Ercolani C, Di Agostino S, Cambria AM, Germoni S, et al: miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis 3: e423, 2012.
32. Chen Z, Sangwan V, Banerjee S, Mackenzie T, Dudeja V, Li X, Wang H, Vickers SM and Saluja AK: miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death. Mol Cancer 12: 105, 2013.
33. Yin Y, Zhang B, Wang W, Fei B, Quan C, Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. Clin Cancer Res 20: 6187-6199, 2014.